Johnson & Johnson’s Acquisition of Shockwave Medical Analysis
Johnson & Johnson Johnson & Johnson’s announcement of its intention to acquire Shockwave Medical for approximately $12.5 billion signifies a significant move…
Browse research
Johnson & Johnson Johnson & Johnson’s announcement of its intention to acquire Shockwave Medical for approximately $12.5 billion signifies a significant move…
The market has been dominated by tech giants in 2024, but Goldman Sachs sees promise in companies other than typical players. Sharmin…
Celcuity LLC (CELC: NSD), a clinical-stage biotech company, is setting its sights on becoming a major player in the fight against cancer.…
Sutro Biopharma (STRO: NSD) has emerged as a potential interest for biotech investors seeking high-growth opportunities. Despite being a penny stock, Sutro…
Stoke Therapeutics Inc (STOK: NSD) saw its stock price soar 73% today after releasing encouraging data from a Phase 1/2 clinical trial…